Trevena Reports Second Quarter 2023 Results and Provides Business Update
Company announces database lock for TRV045 proof-of-concept TMS study evaluating potential for use in epilepsy;…
Company announces database lock for TRV045 proof-of-concept TMS study evaluating potential for use in epilepsy;…
Company announces database lock for TRV045 proof-of-concept TMS study evaluating potential for use in epilepsy;…
– Completed Enrollment in Phase 2/3 V005 Trial of HAV™ in Vascular Trauma Repair; Top-Line…
– Completed Enrollment in Phase 2/3 V005 Trial of HAV™ in Vascular Trauma Repair; Top-Line…
RVT-3101 demonstrated improved efficacy results from the induction to chronic period in the TUSCANY-2 Phase…
RVT-3101 demonstrated improved efficacy results from the induction to chronic period in the TUSCANY-2 Phase…
BOSTON, Aug. 14, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
BOSTON, Aug. 14, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
– Inclusion into the broad-market Russell 3000® Index and small-cap Russell 2000® Index – – Publication…
– Inclusion into the broad-market Russell 3000® Index and small-cap Russell 2000® Index – – Publication…
Business to prioritize high-potential agitation market opportunities for BXCL501 in bipolar disorders, schizophrenia, and Alzheimer’s…
Business to prioritize high-potential agitation market opportunities for BXCL501 in bipolar disorders, schizophrenia, and Alzheimer’s…
— UPNEEQ® remains a significant potential value driver given its rapid early acceptance by providers,…
— UPNEEQ® remains a significant potential value driver given its rapid early acceptance by providers,…
Castellum, Inc. Announces Strong Second Quarter Financial Results Castellum, Inc. (NYSE-American: CTM) (the “Company”), a…
Castellum, Inc. Announces Strong Second Quarter Financial Results Castellum, Inc. (NYSE-American: CTM) (the “Company”), a…
MAINZ, Germany, August 14, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced…
MAINZ, Germany, August 14, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced…
Advanced esports and gaming curricula, tech-driven lesson plans, AR/VR apps, new school partners and learning…
Hybrid Fiber-Copper Networking Solution to be Deployed by New Key Federal Account FREMONT, Calif., Aug….